Zepbound®
A once-weekly injectable Tirzepatide, a dual GLP-1 and GIP receptor agonist, indicated for Type 2 diabetes and approved for weight loss management.
Ozempic for Weight Loss
As you consider the next step in your health journey, know that Ozempic® (semaglutide) could be a pivotal part of your success. Although used off-label for weight management, many have found Ozempic® to be an invaluable ally in achieving significant, sustainable weight loss.
The Science Behind ozempic® for Weight Loss
Ozempic® (semaglutide) operates through a sophisticated mechanism that not only aids in blood sugar control but also promotes weight loss. While its primary FDA approval is for type 2 diabetes, healthcare providers are increasingly recognizing its benefits in weight management when used off-label. By simulating the GLP-1 hormone, it regulates your appetite and caloric intake, which can lead to a reduction in body weight. It’s important to have an open discussion with a healthcare provider about the off-label use of Ozempic® to ensure it aligns with your health goals.
Begin Your Ozempic® Journey Today
At Achieve Health and Weight Loss, we believe in a tailored approach. You’re unique, your weight management plan should be too!
When you embark on your Ozempic® weight loss journey with us, you’ll receive personalized virtual care designed to fit your unique health profile. Our expert team will ensure that a Ozempic® prescription is the right fit for your weight management plan, providing continuous support and guidance every step of the way.
Achieve Community Success
Our community’s success is our greatest pride. Through Ozempic® and other GLP-1 and GIP/GLP-1 medications, members have achieved transformative health milestones, gaining not just a new figure on the scales but a new zest for life. These success stories are not merely numbers; they are narratives of regained confidence and wellness.
Alternative GLP-1 and GIP/GLP-1 Medications
Tirzepatide
A once-weekly injectable GLP-1 and GIP receptor agonist, similar to Mounjaro/Zepbound, compounded for weight loss and diabetes management.
Semaglutide
A once-weekly injectable GLP-1 receptor agonist that mirrors the active ingredient in Wegovy/Ozempic, typically compounded for cost-effective weight loss management.
Wegovy®
A once-weekly injectable GLP-1 receptor agonist (Semaglutide) specifically approved for chronic weight management in adults with obesity or overweight.
Mounjaro®
A once-weekly injectable GLP-1 and GIP receptor agonist indicated for the treatment of Type 2 diabetes and is safe and effective for weight loss.
Transform Your Body, Transfom Your Life!
It’s time to step away from impersonal chatbots and algorithmic goal-setting. Say hello to premier care where our dedicated personal coaches are eager to provide virtual support every step of the way. Whether you experience victories, setbacks, or comebacks, our coaches will be there to lend a helping hand and guide you towards success.
20% Average
Weight Loss
GLP-1 and GIP/GLP-1
medication
